ASH ASHLAND INC.
Wholesale-Chemicals & Allied Products · NYSE · SEC CIK 1674862 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.4%
TTM net income YoY106.0%
TTM EPS YoY105.7%
Revenue 3-yr CAGR-7.2%
Net income 3-yr CAGR-39.8%
Margins
Gross margin31.5%
Operating margin7.4%
Net margin2.8%
FCF margin13.6%
EBITDA margin16.1%
Returns
ROE2.8%
ROA1.1%
ROIC (approx.)2.8%
Asset turnover0.40x
Leverage & solvency
Liabilities / assets59.2%
Debt / equity0.73x
Current ratio3.05x
Interest coverage—
Cash quality & payout
Operating cash flow / net income6.44x
Accruals ratio-6.2%
Payout ratio146.2%
Capex / revenue4.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-09-30 | FY2024*2024-09-30 |
|---|---|---|
| Income statement | ||
| Revenue | $1.82B | $2.11B |
| Cost of revenue | $1.27B | $1.50B |
| Gross profit | $549.00M | $618.00M |
| R&D expense | $54.00M | $55.00M |
| SG&A expense | $344.00M | $404.00M |
| Operating income | -$775.00M | -$26.00M |
| Interest expense | $61.00M | $53.00M |
| Pretax income | -$809.00M | -$24.00M |
| Income tax | $13.00M | -$223.00M |
| Net income | -$845.00M | $169.00M |
| EBITDA | -$538.00M | $248.00M |
| EPS (basic) | -18.23 | 3.40 |
| EPS (diluted) | -18.23 | 3.36 |
| Dividends declared per share | 1.64 | 1.58 |
| Weighted avg. shares (diluted) | 46.00M | 50.00M |
| Banking | ||
| Net interest income | -$33.00M | $24.00M |
| Balance sheet | ||
| Cash & equivalents | $215.00M | $300.00M |
| Receivables | $242.00M | $243.00M |
| Inventory | $568.00M | $545.00M |
| Current assets | $1.21B | $1.20B |
| PP&E, net | $1.20B | $1.30B |
| Goodwill | $705.00M | $1.38B |
| Intangibles | $563.00M | $751.00M |
| Total assets | $4.61B | $5.64B |
| Current liabilities | $423.00M | $490.00M |
| Short-term debt | $0 | $0 |
| Long-term debt | $1.38B | $1.35B |
| Total debt | $1.38B | $1.35B |
| Total liabilities | $2.71B | $2.78B |
| Shareholders' equity | $1.90B | $2.87B |
| Net debt | $1.17B | $1.05B |
| Cash flow statement | ||
| Operating cash flow | $134.00M | $462.00M |
| Capital expenditure | $98.00M | $137.00M |
| Free cash flow | $36.00M | $325.00M |
| Investing cash flow | -$3.00M | -$51.00M |
| Financing cash flow | -$179.00M | -$479.00M |
| Depreciation & amortization | $237.00M | $274.00M |
| Stock-based compensation | $14.00M | $15.00M |
| Dividends paid | $76.00M | $78.00M |
| Share buybacks | $100.00M | $380.00M |
Free plan shows the latest 2 periods; Pro shows all 12 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.